These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8098141)

  • 61. Differential recovery of sensorimotor function in GM1 ganglioside-treated vs. spontaneously recovered MPTP-treated cats: partial striatal dopaminergic reinnervation vs. neurochemical compensation.
    Schneider JS; Schroeder JA; Rothblat DS
    Brain Res; 1998 Nov; 813(1):82-7. PubMed ID: 9824674
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Evoked potentials of the somatic cortex, thalamus, and electromyographic reactions of the cat shoulder muscles elicited by elbow joint straightening in norm and after injection of neurotoxin].
    Dovhalets' HV
    Fiziol Zh (1994); 2005; 51(4):36-44. PubMed ID: 16201148
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Systemic administration of MPTP induces thalamic neuronal degeneration in mice.
    Freyaldenhoven TE; Ali SF; Schmued LC
    Brain Res; 1997 Jun; 759(1):9-17. PubMed ID: 9219857
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The primate subthalamic nucleus. III. Changes in motor behavior and neuronal activity in the internal pallidum induced by subthalamic inactivation in the MPTP model of parkinsonism.
    Wichmann T; Bergman H; DeLong MR
    J Neurophysiol; 1994 Aug; 72(2):521-30. PubMed ID: 7983516
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Circling behaviour in 6-hydroxydopamine-lesioned rats given pulsed levodopa is reduced more by lesions in the entopeduncular nucleus/substantia nigra pars reticulata than in the subthalamic nucleus.
    Honey CR; Shen H
    Neurosci Lett; 1998 Jun; 249(2-3):151-4. PubMed ID: 9682839
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Astrocytic responses to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in cat and mouse brain.
    Schneider JS; Denaro FJ
    J Neuropathol Exp Neurol; 1988 Jul; 47(4):452-8. PubMed ID: 2898510
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Metabolic activity of cerebellar and basal ganglia-thalamic neurons is reduced in parkinsonism.
    Rolland AS; Herrero MT; Garcia-Martinez V; Ruberg M; Hirsch EC; François C
    Brain; 2007 Jan; 130(Pt 1):265-75. PubMed ID: 17148469
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Nigrostriatal lesion and dopamine agonists affect firing patterns of rodent entopeduncular nucleus neurons.
    Ruskin DN; Bergstrom DA; Walters JR
    J Neurophysiol; 2002 Jul; 88(1):487-96. PubMed ID: 12091570
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Role of [corrected] nigrostriatal dopamine system in learning to perform sequential motor tasks in a predictive manner.
    Matsumoto N; Hanakawa T; Maki S; Graybiel AM; Kimura M
    J Neurophysiol; 1999 Aug; 82(2):978-98. PubMed ID: 10444692
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Mouse model of Parkinsonism: a comparison between subacute MPTP and chronic MPTP/probenecid treatment.
    Petroske E; Meredith GE; Callen S; Totterdell S; Lau YS
    Neuroscience; 2001; 106(3):589-601. PubMed ID: 11591459
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on the regional distribution of brain monoamines in the rhesus monkey.
    Pifl C; Schingnitz G; Hornykiewicz O
    Neuroscience; 1991; 44(3):591-605. PubMed ID: 1754053
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Response of caudate neurons to stimulation of intrinsic and peripheral afferents in normal, symptomatic, and recovered MPTP-treated cats.
    Rothblat DS; Schneider JS
    J Neurosci; 1993 Oct; 13(10):4372-8. PubMed ID: 8410193
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Interleukine-1beta and interleukine-6 levels in striatum and other brain structures after MPTP treatment: influence of behavioral lateralization.
    Shen YQ; Hebert G; Lin LY; Luo YL; Moze E; Li KS; Neveu PJ
    J Neuroimmunol; 2005 Jan; 158(1-2):14-25. PubMed ID: 15589033
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effects of dopamine agonists on the spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism.
    Filion M; Tremblay L; Bédard PJ
    Brain Res; 1991 Apr; 547(1):152-61. PubMed ID: 1677608
    [TBL] [Abstract][Full Text] [Related]  

  • 75. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian syndrome in Macaca fascicularis: which midbrain dopaminergic neurons are lost?
    German DC; Dubach M; Askari S; Speciale SG; Bowden DM
    Neuroscience; 1988 Jan; 24(1):161-74. PubMed ID: 3259295
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Differential regulation of striatal preproenkephalin and preprotachykinin mRNA levels in MPTP-lesioned monkeys chronically treated with dopamine D1 or D2 receptor agonists.
    Morissette M; Grondin R; Goulet M; Bédard PJ; Di Paolo T
    J Neurochem; 1999 Feb; 72(2):682-92. PubMed ID: 9930741
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline.
    Kupsch A; Sautter J; Götz ME; Breithaupt W; Schwarz J; Youdim MB; Riederer P; Gerlach M; Oertel WH
    J Neural Transm (Vienna); 2001; 108(8-9):985-1009. PubMed ID: 11716151
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Modifications of precentral cortex discharge and EMG activity in monkeys with MPTP-induced lesions of DA nigral neurons.
    Doudet DJ; Gross C; Arluison M; Bioulac B
    Exp Brain Res; 1990; 80(1):177-88. PubMed ID: 1972680
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Nigral inputs to the pedunculopontine region: intracellular analysis.
    Noda T; Oka H
    Brain Res; 1984 Nov; 322(2):332-6. PubMed ID: 6095971
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice.
    Kurosaki R; Muramatsu Y; Kato H; Watanabe Y; Imai Y; Itoyama Y; Araki T
    Eur Neuropsychopharmacol; 2005 Jan; 15(1):57-67. PubMed ID: 15572274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.